SILCOGUM ORANGE H SILCOPAS BLACK PP FR 8-6 LMS-1000

BLACK 404C TRANSLUCID PP-H-20T-60053 10120PC FR ADDITIVE

X ST-16385-01-01 Black X ET7300-0021 H Natural PP FR 8-6 LMS-1000

M E D I C A L C O N T R AC T M A N U FAC T U R E R A U T O - I N J E C T O R H O U S I N G • Excellent chemical and wear resistance • Excellent impact resistance • Specific color matching based on customer’s needs • Outstanding durability to extend product life • Customized a chemically resistant formulation to offer an impact-modified alternative to traditional competitors in the market • Provided technical support for material selection, part & tool design, and process development to accelerate commercialization • Delivered custom color matching to meet all key requirements Custom Trilliant™ HC Healthcare Thermoplastic KEY REQUIREMENTS WHY AVIENT?

technology H I N G E M A N U FAC T U R E R S P E C I A L T Y F U R N I T U R E F I T T I N G • High dimensional stability • Low slip effect • No squeaking noises • Very low wear properties • High process stability • Provided high quality solutions for mass production with high processing performance • Met customer’s tribological requirements over the entire product life cycle of more than 20 years • Customized tailor-made solutions for specific applications that are constantly being adapted to new requirements LubriOne™ Internally Lubricated Formulations KEY REQUIREMENTS WHY AVIENT?

Bergamid™ FR Non-Halogen Flame Retardant Formulations: specially formulated for high-voltage connectors in a safety orange color, these materials combine the application flexibility of high-flow nylons for thin-wall designs with the performance of a non-halogenated fire retardant system, available in unfilled or reinforced PA6, PA66 and PA 6/66 grades with UL 94 V0 and CTI 800+ ratings  

AVIENT CORPORATION F I R S T Q U A R T E R 2 0 2 3 R E S U L T S (NYSE: AVNT) M A Y 3 , 2 0 2 3 D I S C L A I M E R Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Avient Specialty Formulators Other Specialty / Chemical Companies 2023E(%) 32 79 87 83 81 76 73 90 79 77 76 73 69 60 22 A vi e n t K W R P P G F U L A V Y R P M F M C C E H X L A S H E C L H U N E M N S C L M U LT I P L E E X PA N S I O N Avient Specialty Formulators Other Specialty / Chemical Companies Source: Peer data per Bloomberg as of April 28, 2023 Note: Avient reflects 2023 adjusted EBITDA guidance of $530M and closing share price of $38.51. Avient 2011 and 2018 valuations reflect trailing 12 months EBITDA at December 31 of the respective years. 33 EV / 2023E EBITDA Historic Multiple 6.5 8.3 9.9 14.6 13.7 13.0 11.9 8.8 18.7 17.4 11.8 10.0 9.7 9.1 8.0 7.9 A vi e n t (2 0 1 1 ) A vi e n t (2 0 1 8 ) A vi e n t (2 0 2 3 ) K W R P P G R P M A V Y F U L E C L H X L F M C A S H S C L C E E M N H U N Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

STAN-TONE HCC-34719 SB T-GREEN Soft DV2-35B Black PP FR 8-6 LMS-1000

T-VCP-33547 Yellow BLACK FOAMED PP FR 8-6 LMS-1000

WO9010 WOW-901 BLACK S539.1 PVDF KF-T-1100 CC DBL BLACK PP FR 8-6 LMS-1000